Amita Singh, MD, MS : Research

Neurologist, Vascular Neurologist (Brain Blood Vessel Specialist)

Active clinical trials

SISTER is a Phase-II, prospective, randomized, placebo-controlled, blinded, dose finding trial that aims to determine the safety and preliminary efficacy of TS23, a monoclonal antibody against the alpha-2 antiplasmin (a2-AP), in acute ischemic…

Investigator: Amita Singh
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

My publications

9 publications

2025

Cerebrospinal Creatine Kinase BB Isoenzyme: A Biomarker for Predicting Outcome After Cardiac Arrest.

Neurocritical care

PubMed • Publisher's site

2023

Small-vessel disease in the brain.

American heart journal plus : cardiology research and practice

PubMed • Publisher's site

2022

Cerebral fat embolism syndrome at a single trauma center.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

PubMed • Publisher's site

2021

Taking a Chance to Recover: Families Look Back on the Decision to Pursue Tracheostomy After Severe Acute Brain Injury.

Neurocritical care

PubMed • Publisher's site

2020

Coccidioidomycosis: neurologic manifestations

MedLink Neurology

Active clinical trials

My publications

Filter publications

Cerebrospinal Creatine Kinase BB Isoenzyme: A Biomarker for Predicting Outcome After Cardiac Arrest.

Small-vessel disease in the brain.

Cerebral fat embolism syndrome at a single trauma center.

Taking a Chance to Recover: Families Look Back on the Decision to Pursue Tracheostomy After Severe Acute Brain Injury.

Coccidioidomycosis: neurologic manifestations